SEC Form D · filed February 14, 2017
Miragen Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
William S. Marshall · Boulder, COExec · DirectorBruce L. Booth · Boulder, CODirectorJason A. Leverone · Boulder, COExecJohn W. Creecy · Boulder, CODirectorThomas E. Hughes · Boulder, CODirectorKevin E. Koch · Boulder, CODirectorAdam S. Levy · Boulder, COExecKyle A. Lefkoff · Boulder, CODirectorPaul D. Rubin · Boulder, COExecJoanne M. Lipman · Great Falls, VAExec · DirectorJames M. Brady · Great Falls, VADirectorJoan M. Brady · Great Falls, VADirectorRichard J. Walters Ii · EAST PETERSBURG, PAExecGlen A. Brunk · Indianapolis, INDirectorS. C. Lottich · Indianapolis, INDirectorReuven Dessler · Solon, OHDirectorJoel Goldman · Solon, OHExec · DirectorVincent Deruelle · New York, NYExecBenoit Buridant · New York, NYDirectorKevin E. Koch · Boulder, CODirectorAdam S. Levy · Boulder, COExecKyle A. Lefkoff · Boulder, CODirectorPaul D. Rubin · Boulder, COExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗